Condition

NYHA Class III Heart Failure

ClinicalTrials.gov condition label

Clinical trials8

Recruiting2

Common interventions11

Lead sponsors shown6

Clinical trials

8 shown

NORM-HF Pivotal StudyNCT07574593 · 2026-05-29

Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart FailureNCT07209098 · 2025-11-18

Dietary Tracking in Heart FailureNCT07649148 · 2026-12-01

NOT_YET_RECRUITING

Evaluate the Efficacy and Safety of SPC1001 Low in Patients With Essential HypertensionNCT07064525 · 2024-12-05

ENROLLING_BY_INVITATION

Correlation of SOZO BIS Measures With CardioMEMS PA PressureNCT02939053 · 2017-08-29

Bioimpedance Spectroscopy Compared to CardioMEMS™NCT02857231 · 2017-08-07

Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5CNCT01381172 · 2011-01-01

Wireless, Intermittent Monitoring of Right Heart Pressures in HFNCT01162707 · 2006-12-01

Common interventions

Cardiac Contractility Modulation (CCM)DEVICE1 CardioMEMS HF Pressure Measurement SystemDEVICE1 IVC SensorDEVICE1 Limiting Ultraprocessed Food (UPF) in DietBEHAVIORAL1 No intervention: Optimal medical therapyOTHER1 Optimizer SystemDEVICE1 SOZODEVICE1 SPC1001 LowDRUG1 SPC5002DRUG1 SPC5003DRUG1 SPC5004DRUG1

Leading sponsors

ImpediMed Limited2 Impulse Dynamics2 CardioMEMS1 Foundry Innovation & Research 1, Limited (FIRE1)1 Shin Poong Pharmaceutical Co. Ltd.1 The Cleveland Clinic1

Trial status mix

COMPLETED4

RECRUITING2

ENROLLING_BY_INVITATION1

NOT_YET_RECRUITING1

Phase mix

NA3

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.